“Our passion to develop novel treatments for neurological and related central nervous system disorders is inspired by patients and their families. There is a tremendous need for innovative therapies that will transform the treatment landscape in these areas and meaningfully improve the lives of patients.”
— Uli Hacksell, Ph.D., Chief Executive Officer